Osaic Holdings’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-542
Closed -$21.3K – 7687
2023
Q2
$21.3K Buy
542
+34
+7% +$1.2K ﹤0.01% 5521
2023
Q1
$12.4K Buy
508
+163
+47% +$3.57K ﹤0.01% 5855
2022
Q4
$7K Sell
345
-89
-21% -$1.9K ﹤0.01% 6160
2022
Q3
$8K Buy
434
+420
+3,000% +$5.51K ﹤0.01% 6155
2022
Q2
$0 Buy
+14
New +$176 ﹤0.01% 7732
2021
Q1
– Sell
-135
Closed -$1K – 7012
2020
Q4
$1K Hold
135
– – ﹤0.01% 6317
2020
Q3
$1K Hold
135
– – ﹤0.01% 6117
2020
Q2
$1K Sell
135
-165
-55% -$687 ﹤0.01% 6026
2020
Q1
$1K Buy
+300
New +$1.75K ﹤0.01% 5969

Osaic Holdings's ISEE Position: Q3 2023 in Review

Osaic Holdings sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 542 shares — an estimated $21.3K sold.

Osaic Holdings first reported a position in ISEE in Q1 2020 and held it in 9 quarters. The position peaked at $21.3K in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Osaic Holdings reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Osaic Holdings sold 542 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $21.3K.
  • Osaic Holdings first reported a position in IVERIC bio, Inc. Common Stock in Q1 2020 and held it in 9 quarters.
  • Osaic Holdings's IVERIC bio, Inc. Common Stock position peaked at $21.3K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Osaic Holdings's 13F filing for Q3 2023, filed 13 Nov 2023.